POLL/Neuropathy & Thyroid – Please Join – Thyroid Disorders- MedHelp

Bahn SR, Burch BH, Cooper SD, Garber RJ, Greenlee MC, Klein J, Laurberg P, Mc Dougall JR, Montori M V, Rivkees AS, Ross SD, Sosa AJ, Stan NM: Hyperthyroidism and Other Causes of Thyrotoxicosis: Menagement guidelines of the American Thyroid Association and

Beghi E, Delodovici M, Bogliun G, Crespi V, Paleari F, Gamba P, Capra M, Zarelli M. Hypothyroidism and polyneuropathy. J Neurol Neurosurg Psychiatry 1989 ; 52: 1420-1423

Colman RW, Clowes AW, George JN, Goldhaber SZ, Marder VJ. Overview of hemostasis. In: Colman RW, Marder VJ, Clowes AW, George JN, Goldhaber SZ. Haemostasis and Thrombosis: basic principles and clinical practice. 5th ed. Philadelphia: Lippencott Wiliams &

Degen JL. Genetic interactions between the coagulation and fibrinolytic systems. Thromb Haemost 2001; 86(1):130-7

Akhter MS, Biswas A, Ranjan R, et al. Plasminogen activator inhibitor-1 (PAI-1) gene 4G/5G promoter polymorphism is seen in higher frequency in the Indian patients with deep vein thrombosis. Clin Appl Thromb Hemost. 2010 Apr; 16(2):184-8.

Paunkovic N, Paunkovic J. 1998. Associated Graves' disease and Plummer's disease: Variant of Marine-Lenhart syndrome or distinct clinical entity? 25th Annual Meeting of the European Thyroid Association – Clinical Thyroid Day. Athens 1988 (abstract book).

N.D. Paunkovic, J.A. Paunkovic: Autonomous functioning nodule and Graves' disease. 12th International Thyroid Congress, Kyoto 2000. Page 148 (abst P-171).

Paunkovic N, Paunkovic J. 2003: Associated Graves' and Plummer's disease. Hellenic Journal of Nuclear Medicine, 6(1): 44-47.

Kronenberg HK, Melmed S, Polonsky KS, Larsen PR, eds. 2008. Williams textbook of endocrinology. 11th ed. Philadelphia, PA: Saunders; 505–537.

Funder JW, Carey RM, Fardella C et al. Case Detection, Diagnosis, and Treatment of Patients with Primary Aldosteronism: An Endocrine Society Clinical Practice Guideline. J. Clin. Endocrinol. Metab. 2008; 93:3266–3281.

Hannemann A, Bidlingmaier M, Friedrich N. Screening for primary aldosteronism in hypertensive subjects: results from two German epidemiological studies. Eur J Endocrinol. 2012; 167:7–15.

Republika stručna komisija za izradu i implementaciju vodiča u kliničkoj praksi. Nacionalni vodič za lekare u primarnoj zdravstvenoj zaštiti – Gojaznost. Beograd: Ministarstvo zdravlja Republike Srbije: Centar za izdavačku, bibliotečku i informacionu de

World Health Organization (Internet). Geneva: World Health Organization; Global Strategy on Diet, Physical Activity and Health, c 2006. (updated 2010 April; citated 2010 May 29). Available from: http://www.who.int/dietphysicalactivity/publications/facts/

DG Health and Consumers (Internet). Brussels: Directorate General for Health& Consumers – European Commission; Strategy for Europe on nutrition, overweight and obesity related health issues, implementation progress report, c 2010. (updated 2010 December;

Becker W, Reiners Ch, Borner W. Immunologische Kriterien zur Differentialdiagnose von Schilddrusenerkrankungen, Therapie Woche, 1985, 35:1167–1176.

Becker W, Borner W. Therapeutische Konsequenzen aus der Pathogenese der Hyperthyreose, Die Medizinische Welt, 1986, 37:649–653.

Henning. TRAK-Assay, Prilog uz prospekt, Berlin, 1987.

DeGroot LJ, Pacini F. Thyroid Nodules. http://www.thyroidmanager.org/Chapter18/18–nodulesframe.htm 1-5-2006. 13-2-2009.

Tunbridge WM, Evered DC, Hall R et al. The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol (Oxf) 1977; 7(6): 481–493.

Vander JB, Gaston EA, Dawber TR. The significance of nontoxic thyroid nodules. Final report of a 15-year study of the incidence of thyroid malignancy. Ann Intern Med 1968;69(3): 537–540.

Surks MI, Sievert R. Drugs and thyroid function. New England Journal of Medicine, 1995, 333 (25): 1688–1694.

Lania A, Persani L, Beck-Peccoz P. Central Hypothyreoidism.Pituitary, 2008, 11: 181–186.

Bryan RH. Drugs that supress TSH or cause central hypothyreoidizam. Best Practice&Research Clinical Endocrinology & Metabolism, 2009, 23: 793–800.

Banićević M., Zdravković D., Bogdanović R., Radulović N., Crnčević N., Projekat Prevencija i lečenje gojaznosti kod dece i adolescenata u Srbiji, Institut za štitastu žlezdu i metabolizam - Zlatibor i Udruženje pedijatara Srbije, 2007.

Balboa-Castillo, T.; León-Munoz, L. M..; Graciani, A.; Rodríguez-Artalejo, F.; Guallar- Castillón, P. Longitudinal association of physical activity and sedentary behavior during leisure time with health-related quality of life in community-dwelling older

Biddle, S.; Gorely, T.; Marshall, S. Is Television Viewing a Suitable Marker of Sedentary Behavior in Young People?Annals of Behavioral Medicine, 2009, Vol. 38 Issue 2, p147-153, 7p,